ASBP
Price:
$0.092
Market Cap:
$4.56M
Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.
Industry
Biotechnology
IPO Date
2022-04-11
Stock Exchange
NASDAQ
Ticker
ASBP
According to Aspire Biopharma Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.14. This represents a change of -90.05% compared to the average of -1.41 of the last 4 quarters.
The mean historical PE Ratio of Aspire Biopharma Holdings, Inc. over the last ten years is -788.53. The current -0.14 PE Ratio has changed -98.22% with respect to the historical average. Over the past ten years (40 quarters), ASBP's PE Ratio was at its highest in in the March 2025 quarter at -0.07. The PE Ratio was at its lowest in in the September 2023 quarter at -2017.02.
Average
-788.53
Median
-885.49
Minimum
-1472.52
Maximum
-7.57
Discovering the peaks and valleys of Aspire Biopharma Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.29%
Maximum Annual PE Ratio = -7.57
Minimum Annual Increase = -99.49%
Minimum Annual PE Ratio = -1472.52
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -7.57 | -99.49% |
| 2023 | -1472.52 | 66.29% |
The current PE Ratio of Aspire Biopharma Holdings, Inc. (ASBP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-788.53
5-year avg
-788.53
10-year avg
-788.53
Aspire Biopharma Holdings, Inc.’s PE Ratio is greater than Palisade Bio, Inc. (-1.20), greater than Curis, Inc. (-0.58), greater than Leap Therapeutics, Inc. (-0.80), greater than Entero Therapeutics, Inc. (-0.25), greater than Citius Pharmaceuticals, Inc. (-0.34), greater than Daré Bioscience, Inc. (-1.31), greater than BriaCell Therapeutics Corp. (-2.36), less than Processa Pharmaceuticals, Inc. (-0.00), less than Aditxt, Inc. (-0.00), greater than Hoth Therapeutics, Inc. (-1.54),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.20 | $268.21M | |
| -0.58 | $17.45M | |
| -0.80 | $52.15M | |
| -0.25 | $11.06M | |
| -0.34 | $13.97M | |
| -1.31 | $17.04M | |
| -2.36 | $23.06M | |
| -0.00 | $15.36M | |
| -0.00 | $62.61K | |
| -1.54 | $15.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aspire Biopharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aspire Biopharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Aspire Biopharma Holdings, Inc.'s PE Ratio?
How is the PE Ratio calculated for Aspire Biopharma Holdings, Inc. (ASBP)?
What is the highest PE Ratio for Aspire Biopharma Holdings, Inc. (ASBP)?
What is the 3-year average PE Ratio for Aspire Biopharma Holdings, Inc. (ASBP)?
What is the 5-year average PE Ratio for Aspire Biopharma Holdings, Inc. (ASBP)?
How does the current PE Ratio for Aspire Biopharma Holdings, Inc. (ASBP) compare to its historical average?